176 related articles for article (PubMed ID: 31378787)
1. C-Jun drives melanoma progression in PTEN wild type melanoma cells.
Kappelmann-Fenzl M; Gebhard C; Matthies AO; Kuphal S; Rehli M; Bosserhoff AK
Cell Death Dis; 2019 Aug; 10(8):584. PubMed ID: 31378787
[TBL] [Abstract][Full Text] [Related]
2. In vitro treatment of melanoma brain metastasis by simultaneously targeting the MAPK and PI3K signaling pathways.
Daphu I; Horn S; Stieber D; Varughese JK; Spriet E; Dale HA; Skaftnesmo KO; Bjerkvig R; Thorsen F
Int J Mol Sci; 2014 May; 15(5):8773-94. PubMed ID: 24840574
[TBL] [Abstract][Full Text] [Related]
3. Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism.
Shin S; Asano T; Yao Y; Zhang R; Claret FX; Korc M; Sabapathy K; Menter DG; Abbruzzese JL; Reddy SAG
Mol Cancer Res; 2009 May; 7(5):745-754. PubMed ID: 19435822
[TBL] [Abstract][Full Text] [Related]
4. AP-1/c-Jun transcription factors: regulation and function in malignant melanoma.
Kappelmann M; Bosserhoff A; Kuphal S
Eur J Cell Biol; 2014; 93(1-2):76-81. PubMed ID: 24315690
[TBL] [Abstract][Full Text] [Related]
5. Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells.
Hong IK; Kim YM; Jeoung DI; Kim KC; Lee H
Exp Mol Med; 2005 Jun; 37(3):230-9. PubMed ID: 16000878
[TBL] [Abstract][Full Text] [Related]
6. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
7. Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway.
Lee HY; Crawley S; Hokari R; Kwon S; Kim YS
Int J Oncol; 2010 Apr; 36(4):941-53. PubMed ID: 20198339
[TBL] [Abstract][Full Text] [Related]
8. BRN2 is a non-canonical melanoma tumor-suppressor.
Hamm M; Sohier P; Petit V; Raymond JH; Delmas V; Le Coz M; Gesbert F; Kenny C; Aktary Z; Pouteaux M; Rambow F; Sarasin A; Charoenchon N; Bellacosa A; Sanchez-Del-Campo L; Mosteo L; Lauss M; Meijer D; Steingrimsson E; Jönsson GB; Cornell RA; Davidson I; Goding CR; Larue L
Nat Commun; 2021 Jun; 12(1):3707. PubMed ID: 34140478
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.
Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ
J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786
[TBL] [Abstract][Full Text] [Related]
11. P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformation.
Li T; Zhang J; Zhu F; Wen W; Zykova T; Li X; Liu K; Peng C; Ma W; Shi G; Dong Z; Bode AM; Dong Z
Carcinogenesis; 2011 May; 32(5):659-66. PubMed ID: 21177766
[TBL] [Abstract][Full Text] [Related]
12. Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade.
Ogawa K; Sun C; Horii A
Oncol Rep; 2005 Dec; 14(6):1481-5. PubMed ID: 16273242
[TBL] [Abstract][Full Text] [Related]
13. c-Jun promotes cellular survival by suppression of PTEN.
Hettinger K; Vikhanskaya F; Poh MK; Lee MK; de Belle I; Zhang JT; Reddy SA; Sabapathy K
Cell Death Differ; 2007 Feb; 14(2):218-29. PubMed ID: 16676006
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN.
Packer L; Pavey S; Parker A; Stark M; Johansson P; Clarke B; Pollock P; Ringner M; Hayward N
Carcinogenesis; 2006 Sep; 27(9):1778-86. PubMed ID: 16571650
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
16. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
[TBL] [Abstract][Full Text] [Related]
17. Effects of PTEN Loss and Activated KRAS Overexpression on Mechanical Properties of Breast Epithelial Cells.
Linthicum W; Thanh MH; Vitolo MI; Wen Q
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29848992
[TBL] [Abstract][Full Text] [Related]
18. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
19. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.
Zhao C; Qiao Y; Jonsson P; Wang J; Xu L; Rouhi P; Sinha I; Cao Y; Williams C; Dahlman-Wright K
Cancer Res; 2014 Jul; 74(14):3983-94. PubMed ID: 24830720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
